SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 11th, 2024 • Leap Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledApril 11th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of April 10, 2024, among Leap Therapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser whose name is set forth on Exhibit A (each a “Purchaser” and collectively the “Purchasers”).